The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Background: The renoprotective effect of angiotensin II antagonists has been demonstrated in type 2 diabetic patients with nephropathy but similar data on angiotensin-converting enzyme (ACE) inhibitors are limited. We examined the efficacy and tolerability of fosinopril, an ACE inhibitor with dual hepatic and renal clearance, in 38 type 2 diabetic patients with moderate renal impairment (plasma creatinine 130-300 mu mol/l) over a 2-year period.
著者Tong PCY, Ko GTC, Chan WB, Ma RCW, So WY, Lo MKW, Lee KF, Ozaki R, Chow CC, Cockram CS, Chan JCN
期刊名稱Diabetes, Obesity and Metabolism
出版年份2006
月份5
日期1
卷號8
期次3
出版社BLACKWELL PUBLISHING
頁次342 - 347
國際標準期刊號1462-8902
語言英式英語
關鍵詞Chinese; fosinopril; nephropathy; randomized clinical trial; type 2 diabetes
Web of Science 學科類別Endocrinology & Metabolism; ENDOCRINOLOGY & METABOLISM

上次更新時間 2021-23-04 於 00:01